Disney's ESPN signs deal to air US Open tennis through 2037-March 2024-www.financetom.com

Disney's ESPN signs deal to air US Open tennis through 2037

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Disney's ESPN signs deal to air US Open tennis through 2037

Aug 31, 2024 2:30 AM

BRISTOL, Connecticut, Aug 28 (Reuters) - Walt Disney's ( DIS )

ESPN ( DIS ) signed a deal with the United States Tennis

Association to continue broadcasting the U.S. Open tournament

through 2037, the network said in a statement on Wednesday.

Previous page： Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance Next page： Nvidia's New Chips Likely to Help Extend AI Value Chain Dominance, Analysts Say

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance

Mar 19, 2024

10:58 AM EDT, 03/19/2024 (MT Newswires) -- Cytek Biosciences ( CTKB ) said Tuesday it has appointed William McCombe as chief financial officer, effective immediately, and reaffirmed its full-year 2024 guidance. McCombe succeeds Patrik Jeanmonod, who has served as the company's CFO since 2018. Jeanmonod has been appointed as head of corporate development analytics, the company said. The company said...

Nvidia's New Chips Likely to Help Extend AI Value Chain Dominance, Analysts Say

Mar 19, 2024

10:58 AM EDT, 03/19/2024 (MT Newswires) -- Nvidia's ( NVDA ) new Blackwell computing platform, along with a series of artificial intelligence chips, should give the semiconductor maker a competitive edge in the AI accelerator market, multiple analysts said on Tuesday. The offerings, announced during its developer's conference in San Jose, included the B100, B200, and GB200 chips. The company's...

XPeng Fourth-Quarter Revenue Climbs, Loss Narrows; Guides Top-Line Momentum Through First Quarter

Mar 19, 2024

10:57 AM EDT, 03/19/2024 (MT Newswires) -- XPeng ( XPEV ) reported a sharp jump in fourth-quarter revenue and a reduced per-share loss Tuesday, with deliveries nearly tripling year over year, and guided for ongoing revenue momentum despite short-term challenges. Revenue climbed to 13.05 billion renminbi ($1.84 billion) for the three months ended Dec. 31 from 5.14 billion renminbi the...

Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics

Mar 19, 2024

11:02 AM EDT, 03/19/2024 (MT Newswires) -- Centogene ( CNTG ) said Tuesday it will continue to give Takeda Pharmaceutical ( TAK ) access to diagnostic testing for patients with Lysosomal Storage Disorders, or LSDs, under the companies' extended agreement. Centogene ( CNTG ) said the companies entered into the partnership to improve patient access to testing for disorders such...